AAB
GILD icon

ABN AMRO Bank’s Gilead Sciences GILD Stock Holding History

ABN AMRO Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.2M Sell
191,290
-4,434
-2% -$584K 0.31% 61
2026
Q1 		$27.5M Sell
195,724
-27,117
-12% -$3.8M 0.3% 59
2025
Q4 		$27.3M Buy
222,841
+176,750
+383% +$21.5M 0.26% 60
2025
Q3 		$5.14M Buy
+46,091
New +$5.24M 0.05% 112
2024
Q1 		– Sell
-8,194
Closed -$665K – 157
2023
Q4 		$665K Hold
8,194
– – 0.01% 128
2023
Q3 		$613K Buy
8,194
+576
+8% +$44.3K 0.01% 122
2023
Q2 		$587K Buy
+7,618
New +$608K 0.01% 119

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ABN AMRO Bank's GILD Position: Q2 2026 in Review

ABN AMRO Bank reduced its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, selling an estimated $584K and leaving 191,290 shares worth $24.2M. The position accounts for 0.31% of the portfolio, ranked #61.

ABN AMRO Bank first reported a position in GILD in Q2 2023 and has held it in 7 quarters since. The position peaked at $27.5M in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • ABN AMRO Bank held 191,290 shares of Gilead Sciences worth $24.2M as of Q2 2026.
  • ABN AMRO Bank sold 4,434 Gilead Sciences shares in Q2 2026, an estimated $584K.
  • Gilead Sciences made up 0.31% of ABN AMRO Bank's portfolio in Q2 2026, its #61 holding.
  • ABN AMRO Bank first reported a position in Gilead Sciences in Q2 2023 and has held it in 7 quarters since.
  • ABN AMRO Bank's Gilead Sciences position peaked at $27.5M in Q1 2026.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on ABN AMRO Bank's 13F filing for Q2 2026, filed 6 Aug 2026.